Geon BIO materials are formulated with PolyOne’s plant-based reFlex™ 300 plasticizer, which has been tested and certified by the United States Department of Agriculture’s BioPreferred® Program to be 99 percent bio-based. In addition, specific Geon BIO healthcare formulations are pre-certified to meet biocompatibility requirements for United States Pharmacopeia (USP) Class VI protocols.

Independent Registered Public Accountant Services and Related Fee Arrangements Report of the Audit Committee The Audit Committee of the Board of Directors Director Independence Lead Director Board Leadership Structure Board’s Oversight of Risk Code of Ethics, Code of Conduct and Corporate Governance Guidelines Communication with Board Board and Committees Board Attendance Board Committees AAudit Committee – Primary Responsibilities and Requirements MEETINGS IN 2018: 9 Compensation Committee – Primary Responsibilities and Requirements MEETINGS IN 2018: 5 MEMBERS: Nominating and Governance Committee – Primary Responsibilities and Requirements MEETINGS IN 2018: 4 Environmental, Health and Safety Committee – Primary Responsibilities and Requirements MEETINGS IN 2018: 3 Board Refreshment 0% 20% 40% 60% 80% 100% 5 or fewer 6 to 10 More than 10 Years of Service NON-EMPLOYEE DIRECTOR COMPENSATION 2018 NON-EMPLOYEE DIRECTOR COMPENSATION Role Annual Cash Retainers 2018 Director Compensation Table Fees Earned or Paid in Cash Stock Awards Total (1) NON-EMPLOYEE DIRECTOR COMPENSATION Fees Earned or Paid in Cash (column (a)) Stock Awards (column (b)) Option Awards Outstanding and Fully-Vested Deferred Shares Number of Deferred Shares(1) Beneficial Ownership of Our Common Shares Owned(1) Right to Acquire Shares Total Beneficial Ownership Name and Address Shares % of Shares Stock Ownership Guidelines for Non-Employee Directors Section 16(a) Beneficial Ownership Reporting Compliance Executive Summary Name Title How Pay is Tied to Company Performance. Exercise or Base Price of Option Awards (column (i)) Grant Date Fair Value of Stock and Option Awards (column (j)) Narrative Disclosure Relating to the 2018 Summary Compensation Table and the 2018 Grants of Plan-Based Awards Table Outstanding Equity Awards at 2018 Fiscal Year-End Exercise Price Expiration Date Market Value of Shares or Units of Stock That Have Not Vested Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested (j) Stock Awards Equity Incentive Plan Awards: Number of Securities Underlying Unearned Options Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (i) Number of Shares or Units of Stock That Have Not Vested Number of Underlying Unexercised Options (#) Unexercisable Number of Securities Underlying Options (#) Exercisable Option Awards Number of Securities Underlying Unexercised Options (#) Exercisable (column (b)) Number of Securities Underlying Unexercised Options (#) Unexercisable (column (c)) Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (column (d)) Option Exercise Price (column (e)) Option Expiration Date (column (f)) Number of Shares or Units of Stock That Have Not Vested (column (g)) Market Value of Shares or Units of Stock That Have Not Vested (column (h)) Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (column (i)) Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (column (j)) 2018 Option Exercises and Stock Vested Option Awards Stock Awards Acquired on Exercise Value Realized on Exercise Acquired on Vesting Value Realized on Vesting Option Awards (columns (b) and (c)) Stock Awards (columns (d) and (e)) 2018 Nonqualified Deferred Compensation Aggregate Executive Registrant Aggregate Aggregate Aggregate Balance at Contributions Contributions Earnings Withdrawals/ Balance at in Last FY in Last FY in Last FY Distributions Last FYE (1) ($)(2) ($)(3) ($)(4) ($) ($)(1)(5) Potential Payments Upon Termination or Change of Control Summary of Potential Payments Management Continuity Agreements Executive Severance Plan Annual Plan Long-Term Incentive Awards Retirement Benefits Payments and Benefits Upon Termination — As of the End of Fiscal Year 2018 CEO Pay Ratio Disclosure CEO Annual Total Compensation for 2018: $6,127,920 Median Employee Annual Total Compensation for 2018: $48,056 Ratio of CEO to Median Employee Annual Total Compensation for 2018: 128:1 How the Median Employee was Determined in 2017 Compensation Committee Interlocks and Insider Participation Policy on Related Person Transactions Risk Assessment of the Compensation Programs Compensation Committee Report The Compensation Committee of the Board of Directors MISCELLANEOUS MISCELLANEOUS PROVISIONS Voting at the Meeting not Shareholder Proposals MISCELLANEOUS Proxy Solicitation We will furnish without charge to each person from whom a proxy is being solicited, upon written request of any such person, a copy of the Annual Report on Form 10-K of the Company for the fiscal year ending December 31, 2018, as filed with the SEC, including the financial statements and schedules thereto.

The acquired businesses design and produce innovative, lightweight, high-performance solutions, utilizing advanced composite technology and state-of-the-art manufacturing capabilities. SEC Filings

Patterson further stated.  SEC Filings

Reporting & SEC Filings

Spiral flow testing results for GLS products are presented below using injection speeds of 3 in/sec and 5 in/sec. Special TPEs can achieve up to 40 inches at an injection speed of 5 in/sec.

Broad processing speeds from 25 mm/sec to 75 mm/sec result in outstanding adhesion as shown in Figure 6. F O m C O *C n C* O *m *z C C C N HH * x y C H 3 O C H 3 O* O C *n 285-056 Peel adhesion 3.23 3.06 3.063.063.062.89 2.89 2.89 2.72 2.72 3.06 2.38 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 Lexan 141 Cycolac MG38 Cycoloy C2950 Xenoy 5220 Xenoy 1339 Injection speed: 25 mm/sec l, Melt temp: 190°C Melt temp: 200°C Melt temp: 220°C Figure 5: GLS 285-056 adhesion values overmolded onto PC, ABS, PC/ABS and PC/PBT over a wide range of melt emperatures of the TPE. t 285-056 peel adhesion 2.893.06 2.38 2.55 2.55 3.063.06 25 50 75 Injection velocity, mm/sec l, Lexan 141 Cycolac MG38 Cycoloy C2950 Xenoy 5220 Figure 6: GLS 285-056 adhesion values overmolded onto PC, ABS, PC/ABS and PC/PBT over a wide range of injection peeds. s 285-056 tensile properties: initial & aged after 1 week at 70°C. 2.35 1.60 2.77 2.30 1.66 2.77 Figure 7: Physical property retention of GLS 285-056 after 1week at 70°C. OM6240 adhesion to Ultramid B3ZG6 1.7 1.91.9 0.0 1.0 2.0 250°C 260°C 270°C Melt temperature l, Injection speed: 64 mm/sec Figure 10: Versfalex OM 6240 adhesion values to polyamide Ultrmid B3ZG6 OM6240 adhesion to Ultramid B3ZG6 1.7 1.91.9 0.0 1.0 2.0 250°C 260°C 270°C Melt temperature l, Injection speed: 64 mm/sec Figure 11: Versaflex OM 6258 adhesion values to polyamide Ultrmid B3ZG6 GLS Corporation, 833 Ridgeview Drive, McHenry, IL 60050

Formulations are heavy metal-free and manufactured using state-of-the- art pigment dispersion techniques that improve homogenization and color distribution. Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales representative for property ranges and min/max specifications. Processing conditions can cause material properties to shift from the values stated in the information.